Last reviewed · How we verify
NCT05772078
Compliance and Cumulative Interceptive Rate After Therapy of Peri-implantitis
trial testing Assess compliance rate and demographics in Peri-Implantitis in 140 participants. Completed in 30 October 2023.
1 July 2023
Quick facts
| Lead sponsor | Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, Spain |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 140 |
| Start date | 1 July 2023 |
| Primary completion | 1 July 2023 |
| Estimated completion | 30 October 2023 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Assess compliance rate and demographics
Conditions studied
- Peri-Implantitis — all drugs for Peri-Implantitis →
Sponsor
Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, Spain — full company profile →
Who can join
Adults 18 to 85, any sex, with Peri-Implantitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Peri-implantitis is a plaque-mediated inflammatory condition featured by progressive bone loss. This entity jeopardizes the longevity of dental implants, thus impacting negatively on the quality of life of patients. Moreover, peri-implantitis is suggested to lead to an increased systemic status of inflammation. This may rise the susceptibility to experience life-threating conditions. Therefore, peri-implant infections must be promptly diagnosed and eliminated. Aiming at resolving the inflammation, several options are advised to remove the infection. Accordingly, implant removal or therapeutic manoeuvres to stablish a healthy ecosystem in the peri-implant environment have been suggested. While the former proved being more predictable, the later demonstrated being more conservative. Indeed, implant removal is commonly associated with regenerative procedures of the alveolar bone deformity that often demand time and is more costly. Anyways, disease severity, implant expendability for biomechanical reasons or esthetic demand seem to be few of the leading aspects in the decision-making process on maintaining or extracting implant showing peri-implant lesions. Supportive maintenance care (SPT) was shown to be key in preventing disease recurrence. Nonetheless, the compliance of these patients is often erratic. In fact, it is yet unknown the rate of compliance after therapy. Therefore, the goal of this study is to assess the rate and confounders for compliance.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Supportive therapy following peri-implantitis treatment: A retrospective study on compliance.
Monje A, Galindo-Fernández P, Nart J. · · 2024 · cited 9× · PMID 38530213 · DOI 10.1111/clr.14257
Verify or expand the search:
- PubMed search for NCT05772078
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Peri-Implantitis
Currently open trials in the same condition.
- NCT07012915 — Immunological-Clinical Evaluation of the Etiopathogenesis of Peri-Implantitis · NA · recruiting
- NCT06679283 — Surgical Treatment of Peri-implantitis With Adjunctive Application of Platelet Rich Fibrin (PRF) · NA · recruiting
- NCT06017817 — Antibacterial Photodynamic Therapy in the Management of Peri-implantitis · NA · recruiting
- NCT06364982 — Distance Between Dental Implants as a Risk Indicator for Peri-implant Disease. · recruiting
- NCT06288919 — Erythritol vs Ultrasonic Scaler Prophylaxis Systems on Dental Implants With Crowns Made by Different Materials · NA · active not recruiting
Other Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, Spain trials
Trials by the same sponsor.
- NCT06398288 — Adjunctive Use of Dermal Matrix to Compensate Dimensional Changes in the Reconstructive Therapy of Peri-implantitis · NA · recruiting
- NCT06390124 — Reconstructive Therapy of Peri-implantitis with PDGF-BB (Gem-21) · Phase 4 · completed
- NCT05615051 — Influence of Implant Surface Decontamination on the Reconstructive Outcomes of Peri-implantitis · NA · active not recruiting
- NCT04410614 — Dimensional Changes of Free Epithelial Graft at Teeth and Implant Sites · NA · completed
- NCT05282667 — Reconstructive Management of Peri-implantitis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05772078 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, Spain
- Last refreshed: 30 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05772078.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing